Open innovation is often suggested as a solution to enhance productivity in under-performing areas of research. Now, the strengths and weaknesses of a new open innovation model in drug discovery have been evaluated.
Mar 25, 2014
Stem cell research, biodiversity, and genetically modified foods are just three facets of biotechnology that pose challenging policy questions. RAND biotechnology research has assessed the role of the U.S. National Bioethics Advisory Commission, explored the global technology revolution, examined pharmaceutical innovation, and studied health and medical research in several Western countries.